Nuvectis Pharma, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-21: Form 8-K; Exhibit 10.1; Description Open Market Sale Agreement, dated August 21, 2026, by and between Nuvectis Pharma, Inc. and Jefferies LLC..
- 2025-05-09: Form 8-K; Exhibit 10.1; Description Sales Agreement, dated May 9, 2025, by and between Nuvectis Pharma, Inc. and Leerink Partners LLC..
- 2022-07-29: Form 8-K; Exhibit 10.4; Description Form of Registration Rights Agreement by and among Nuvectis Pharma, Inc. and the Purchasers, dated July 27, 2022..
- 2022-07-29: Form 8-K; Exhibit 10.3; Description Form of Pre-Funded Stock Purchase Warrant..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-21 | 8-K | 10.1 | Open Market Sale Agreement, dated August 21, 2026, by and between Nuvectis Pharma, Inc. and Jefferies LLC. |
|---|
| 2025-05-09 | 8-K | 10.1 | Sales Agreement, dated May 9, 2025, by and between Nuvectis Pharma, Inc. and Leerink Partners LLC. |
|---|
| 2022-07-29 | 8-K | 10.4 | Form of Registration Rights Agreement by and among Nuvectis Pharma, Inc. and the Purchasers, dated July 27, 2022. |
|---|
| 2022-07-29 | 8-K | 10.3 | Form of Pre-Funded Stock Purchase Warrant. |
|---|
| 2022-07-29 | 8-K | 10.2 | Form of Preferred Investment Option. |
|---|
| 2022-07-29 | 8-K | 10.1 | Form of Securities Purchase Agreement by and among Nuvectis Pharma, Inc. and the Purchasers, dated July 27, 2022. |
|---|